PCI Pharma extends global clinical supply-chain services in Europe

By Akshay Kedari  | Date: 2020-07-30

PCI Pharma extends global clinical supply-chain services in Europe

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin.

According to credible sources, the new COE facility is PCI Pharma’s efforts to extend its clinical supply-chain network in Europe, which would complement the existing services it provides in Ireland and UK.

The Berlin-based COE will cover a space of 17,000 square feet which will primarily focus on packaging, storing and distribution of pharmaceutical and biopharmaceutical therapies in Europe, sources claimed.

The facility is reportedly ideal to provide services to clinical trials eco-system in the region. It presently has around 38,100 active trial centers across Europe, of which France ranks first with 7,370 active trials followed by Germany, with around 4,418 trial centers.

VP and GM of Global Clinical Operations & Supply at PCI Pharma Services, Brian Keesee reportedly said that this expansion will enable the company to cater to the needs of European as well as global clients through the COE facility in Berlin. He further claimed that Berlin is an exceptional logistics center and will ensure minimum disruptions in the supply-chain amid Brexit.

Salim Haffar, CEO at PCI Pharma Services, also stated that the company’s strategy has always focused on increasing the capacity as well as the capabilities of its network of clinical trial services. He added that the recent acquisition of Bellwyck Pharma Services will enable PCI Pharma to improve its capabilities through the Berlin facility, in a bid to support the flourishing clinical trial sector in Europe.

Salim also confirmed that the recent investment will facilitate the company to offer clinical trial solutions of their advanced medicines to clients across the globe.

For those uninitiated, PCI Pharma is a major contributor to global healthcare industry since it offers drug development solutions that help in enhancing numerous medical products.

Source credits: https://www.businesswire.com/news/home/20200728005211/en/PCI-Pharma-Services-Announces-Global-Expansion-Clinical

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

By Akshay Kedari

After Ukraine’s invasion, multinational fast-food giant McDonald's Corp. is reportedly planning to sell all its restaurants in Russia, pulling operations from the nation after 30 years. The world's biggest fast-food chain closed 847 ...

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

By Akshay Kedari

GetHenry, a Berlin-based company that offers couriers and logistics organizations electric last-mile delivery bikes, has reportedly raised USD 17.4 million seed round to grow its operations across Europe. The latest investment round was led by LocalG...

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

By Akshay Kedari

Italian luxury sports car manufacturer Ferrari S.p.A. will equip its much-awaited Purosangue SUV with a 12-cylinder engine, as it focused more on fuel-efficient models. Confirming the news, Ferrari Chief Executive Benedetto Vigna claimed that the com...

White House to spend USD 3 billion on EV battery manufacturing in U.S.

White House to spend USD 3 billion on EV battery manufacturing in U.S.

By Akshay Kedari

According to reliable sources, the Biden administration is planning to provide USD 3 billion in finance to reinforce EV battery manufacturing capabilities in the United States. The apparent funds will be issued by the Department of Energy from Presid...

Telefonica eyeing Israel’s high-tech sector to improve its portfolio

Telefonica eyeing Israel’s high-tech sector to improve its portfolio

By Akshay Kedari

Telefonica S.A. is planning to increase its investments in Israel’s high-tech sector this year, a senior official reported recently. The company, which is Europe’s third-largest telecommunications company, is also eyeing the country&rsquo...